Opportunity Information: Apply for PAR 08 205

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIDCD Phase III Definitive Clinical Trials in Communication Disorders (R01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173 Research Related to Deafness and Communication Disorders.
  • This funding opportunity was created on Mar 23, 2012 and posted on Jul 16, 2008.
  • Applicants must submit their applications by Mar 24, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: County governments City or township governments Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Small businesses Special district governments Native American tribal governments (Federally recognized) Others (see text field entitled Additional Information on Eligibility for clarification) State governments.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for PAR 08 205

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The NIDCD Phase III Definitive Clinical Trials in Communication Disorders (R01) funding opportunity (PAR-08-205) is a National Institutes of Health grant program designed to support rigorous, investigator-initiated Phase III definitive clinical trials aimed at establishing treatments or interventions that are both safe and effective for communication disorders. The emphasis is on late-stage trials that are ready to provide clear, practice-changing answers. Projects proposed under this announcement are expected to be capable of producing results that could meaningfully influence clinical practice guidelines and/or inform public health policy if the intervention proves successful.

A key expectation of this opportunity is that applicants are not starting from scratch. By the time a team applies for this Phase III definitive trial support, the underlying foundation should already be in place, including adequate preclinical evidence and preliminary clinical findings that justify moving into a definitive Phase III trial. In addition, the major design and operational questions that can derail large trials should already be resolved before submission. That includes having core clinical and methodological decisions worked out in advance, such as the target population definition, primary and secondary outcomes, recruitment and retention strategies, randomization and masking where appropriate, intervention delivery procedures, data collection workflows, safety oversight plans, and data management/quality control approaches.

One of the most important concrete requirements in the announcement is the expectation of a complete Manual of Procedures (MOP). The MOP is not optional: it must be included as an appendix to the Phase III Definitive Clinical Trial application. This requirement signals that NIDCD is looking for proposals that are operationally ready to run, with standardized procedures clearly documented so that trial conduct is consistent across staff, sites, and participants. The FOA also notes that applicants can use earlier-stage NIDCD mechanisms to prepare for this step, specifically the NIDCD Clinical Trial Planning Grant (R34) (PAR-08-203) and/or the NIDCD Phase I/II Preliminary Clinical Trial FOA (PAR-08-204), which are intended to help gather the remaining planning information and develop the MOP needed for a Phase III launch.

In terms of award structure, the program uses the NIH Research Project Grant (R01) mechanism as the default. However, the announcement includes an important caveat: if a project is a multicenter Phase III definitive clinical trial or if it requests $500,000 or more in direct costs in any grant year, the award will be converted to a cooperative agreement mechanism (U01). That conversion generally indicates a higher level of NIH programmatic involvement and coordination expectations typical for large, complex, and/or multicenter clinical trials.

Funding under this FOA is contingent on appropriations and on the availability of a sufficient number of highly rated, meritorious applications, and the announcement does not guarantee a specific number of awards. The program is categorized as discretionary funding and falls under the health funding activity category, with CFDA number 93.173 (Research Related to Deafness and Communication Disorders). There is no cost sharing or matching requirement.

Eligibility is broad and includes many types of organizations that commonly apply for NIH funding. Eligible applicants listed include state, county, city/township, and special district governments; public and private institutions of higher education; independent school districts; public housing authorities/Indian housing authorities; nonprofits both with and without 501(c)(3) status; and for-profit organizations other than small businesses, as well as small businesses. Tribal entities are included, both federally recognized tribal governments and other tribal organizations, and the eligibility information also explicitly references Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), regional organizations, faith-based or community-based organizations, eligible federal agencies, and U.S. territories or possessions.

Administratively, the opportunity was posted July 16, 2008, later recorded with a creation date of March 23, 2012, and it is archived (original closing date September 7, 2012; current closing date shown as March 24, 2012; archive date April 24, 2012). The full announcement is referenced through the NIH grants guide, and the NIH Office of Extramural Research provides a webmaster contact for access or linking issues.

FAQs: NIDCD Phase III Definitive Clinical Trials in Communication Disorders (R01) (PAR-08-205)

What is this funding opportunity?

This opportunity (PAR-08-205) is an NIH/NIDCD grant program that supports rigorous, investigator-initiated Phase III definitive clinical trials focused on treatments or interventions for communication disorders.

What is the main purpose of the trials funded under this announcement?

The goal is to run late-stage (Phase III) definitive clinical trials designed to establish whether an intervention is both safe and effective, with results strong enough to deliver clear, practice-changing answers.

What kind of impact is NIDCD looking for from supported trials?

Projects are expected to be capable of producing results that could meaningfully influence clinical practice guidelines and/or inform public health policy if the intervention proves successful.

Are early-stage or exploratory studies a fit for this FOA?

This FOA emphasizes Phase III definitive trials that are operationally and scientifically ready to produce clear answers. It is not described as a starting point for teams that still need to establish basic feasibility or resolve major trial design questions.

What level of prior evidence is expected before applying?

Applicants are expected to have adequate preclinical evidence and preliminary clinical findings already in place that justify moving into a definitive Phase III trial.

What planning and design issues are expected to be resolved before submission?

The announcement emphasizes that major design and operational questions that can derail large trials should already be resolved. Examples explicitly referenced include:

  • Clear definition of the target population
  • Primary and secondary outcomes
  • Recruitment and retention strategies
  • Randomization and masking (where appropriate)
  • Intervention delivery procedures
  • Data collection workflows
  • Safety oversight plans
  • Data management and quality control approaches

Is a Manual of Procedures (MOP) required?

Yes. A complete Manual of Procedures (MOP) is required and must be included as an appendix to the Phase III Definitive Clinical Trial application. The MOP is described as not optional.

Why does the FOA emphasize the Manual of Procedures (MOP)?

The requirement signals that NIDCD is looking for trials that are operationally ready to run, with standardized procedures documented so trial conduct is consistent across staff, sites, and participants.

Are there NIDCD mechanisms mentioned that can help teams prepare for a Phase III trial and develop the MOP?

Yes. The FOA notes that applicants can use earlier-stage NIDCD mechanisms to prepare, including the NIDCD Clinical Trial Planning Grant (R34) (PAR-08-203) and/or the NIDCD Phase I/II Preliminary Clinical Trial FOA (PAR-08-204).

What is the default NIH funding mechanism for this opportunity?

The default mechanism is the NIH Research Project Grant (R01).

When does an application get converted from an R01 to a U01?

The announcement states that the award will be converted to a cooperative agreement (U01) if the project is a multicenter Phase III definitive clinical trial or if it requests $500,000 or more in direct costs in any grant year.

What does conversion to a U01 imply based on the announcement?

The FOA notes that conversion generally indicates a higher level of NIH programmatic involvement and coordination expectations typical for large, complex, and/or multicenter clinical trials.

Is funding guaranteed? How many awards will be made?

No specific number of awards is guaranteed. Funding is contingent on appropriations and on the availability of a sufficient number of highly rated, meritorious applications.

Is there a cost sharing or matching requirement?

No. The announcement specifies that there is no cost sharing or matching requirement.

What is the CFDA number and program category listed for this opportunity?

The CFDA number is 93.173 (Research Related to Deafness and Communication Disorders). The program is described as discretionary funding and falls under the health funding activity category.

Who is eligible to apply?

Eligibility is broad and includes a wide range of organization types commonly eligible for NIH funding. The FOA lists eligible applicants including:

  • State, county, city/township, and special district governments
  • Public and private institutions of higher education
  • Independent school districts
  • Public housing authorities/Indian housing authorities
  • Nonprofits with and without 501(c)(3) status
  • For-profit organizations (including small businesses and other than small businesses)
  • Tribal entities, including federally recognized tribal governments and other tribal organizations
  • U.S. territories or possessions
  • Eligible federal agencies
  • Regional organizations
  • Faith-based or community-based organizations

Does the eligibility language explicitly include certain institution types such as HBCUs or Hispanic-serving institutions?

Yes. The eligibility information explicitly references Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), and related categories.

Is this funding opportunity still open?

No. The opportunity is described as archived, with the original closing date listed as September 7, 2012, a current closing date shown as March 24, 2012, and an archive date of April 24, 2012.

When was the opportunity posted and when was it recorded as created?

The opportunity was posted on July 16, 2008, and is later recorded with a creation date of March 23, 2012.

Where is the full announcement referenced?

The full announcement is referenced through the NIH grants guide.

Who is listed as a contact for access or linking issues?

The NIH Office of Extramural Research provides a webmaster contact for access or linking issues.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Investigations on Primary Immunodeficiency Diseases (R01)

Previous opportunity: NIDCD Phase I/II Preliminary Clinical Trials in Communication Disorders (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 08 205

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 08 205) also looked into and applied for these:

Funding Opportunity
Deep Sequencing and Haplotype Profiling of Mental Disorders (R01) Apply for PA 08 198

Funding Number: PA 08 198
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Addressing the Mental Health Needs of Returning Combat Veterans in the Community (R01) Apply for RFA MH 09 070

Funding Number: RFA MH 09 070
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Deep Sequencing and Haplotype Profiling of Mental Disorders (Collaborative R01) Apply for PAR 08 199

Funding Number: PAR 08 199
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Exploratory/Developmental Projects in Translational Research for Neuromuscular Disease (R21) Apply for PAR 08 228

Funding Number: PAR 08 228
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Translational Research at the Aging/Cancer Interface (TRACI) (R01) Apply for PA 08 230

Funding Number: PA 08 230
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Translational Research at the Aging/Cancer Interface (TRACI) (R21) Apply for PA 08 231

Funding Number: PA 08 231
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
NINDS Exploratory/Developmental Projects in Translational Research (R21) Apply for PAR 08 232

Funding Number: PAR 08 232
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Aging Research Dissertation Awards to Increase Diversity (R36) Apply for PAR 08 250

Funding Number: PAR 08 250
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Archiving and Development of Socialbehavioral Datasets in Aging Related Studies (R03) Apply for PA 08 252

Funding Number: PA 08 252
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Functioning of People with Mental Disorders (R01) Apply for PA 08 255

Funding Number: PA 08 255
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
The Effects of Alcohol on Glial Cells (R01) Apply for RFA AA 09 003

Funding Number: RFA AA 09 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
The Effects of Alcohol on Glial Cells (R21) Apply for RFA AA 09 004

Funding Number: RFA AA 09 004
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Follow up Public Consultation to Inform the Design of a Possible Longitudinal Cohort Study of the Role of Genes and Environment in Health and Disease Limited Competition (U01) Apply for RFA HG 09 004

Funding Number: RFA HG 09 004
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
National Institute of Mental Health (NIMH) Career Opportunities in Research (COR) Honors Undergraduate Research Training Grant (T34) Apply for PAR 08 093

Funding Number: PAR 08 093
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Researching Implementation and Change while Improving Quality (R18) Apply for PAR 08 136

Funding Number: PAR 08 136
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
NEI CAREER TRANSITION AWARD (K22) Apply for PAR 04 136

Funding Number: PAR 04 136
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Career Development Award to Promote Diversity in Neuroscience Research Apply for PAR 05 071

Funding Number: PAR 05 071
Agency: National Institutes of Health
Category: Health
Funding Amount: $50,000
AHRQ Mentored Clinical Scientist Development Award (K08) Apply for PAR 07 443

Funding Number: PAR 07 443
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
AHRQ Independent Scientist Award (K02) Apply for PAR 07 444

Funding Number: PAR 07 444
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
AHRQ Mentored Research Scientist Development Award (K01) Apply for PAR 08 022

Funding Number: PAR 08 022
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 08 205", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.